NCT05345808View on ClinicalTrials.gov

Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

February 20, 2022

Study Completion Date

March 30, 2022

Conditions

Retinal Vein Occlusion

Interventions

DRUG

Triamcinolone Acetonide

Triamcinolone Acetonide formulated with chondroitin sulfate and sodium hyaluronate

Trial Locations (1)

34517

Akram Fekry Elgazzar, Damietta

All Listed Sponsors

lead

Al-Azhar University

OTHER

NCT05345808 - Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions | Biotech Hunter | Biotech Hunter